chr11-44096348-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_207122.2(EXT2):c.-31+496T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.717 in 1,531,358 control chromosomes in the GnomAD database, including 395,996 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.71 ( 37746 hom., cov: 28)
Exomes 𝑓: 0.72 ( 358250 hom. )
Consequence
EXT2
NM_207122.2 intron
NM_207122.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.96
Genes affected
EXT2 (HGNC:3513): (exostosin glycosyltransferase 2) This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of multiple exostoses. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 11-44096348-T-G is Benign according to our data. Variant chr11-44096348-T-G is described in ClinVar as [Benign]. Clinvar id is 1287445.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-44096348-T-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.889 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.706 AC: 106253AN: 150574Hom.: 37705 Cov.: 28 show subpopulations
GnomAD3 genomes
AF:
AC:
106253
AN:
150574
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.751 AC: 101402AN: 134962 AF XY: 0.748 show subpopulations
GnomAD2 exomes
AF:
AC:
101402
AN:
134962
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.719 AC: 992320AN: 1380666Hom.: 358250 Cov.: 34 AF XY: 0.719 AC XY: 489668AN XY: 681166 show subpopulations
GnomAD4 exome
AF:
AC:
992320
AN:
1380666
Hom.:
Cov.:
34
AF XY:
AC XY:
489668
AN XY:
681166
Gnomad4 AFR exome
AF:
AC:
19000
AN:
31464
Gnomad4 AMR exome
AF:
AC:
30053
AN:
35622
Gnomad4 ASJ exome
AF:
AC:
17186
AN:
25080
Gnomad4 EAS exome
AF:
AC:
32213
AN:
35630
Gnomad4 SAS exome
AF:
AC:
57857
AN:
79108
Gnomad4 FIN exome
AF:
AC:
26158
AN:
33838
Gnomad4 NFE exome
AF:
AC:
764854
AN:
1076842
Gnomad4 Remaining exome
AF:
AC:
41322
AN:
57748
Heterozygous variant carriers
0
14543
29086
43629
58172
72715
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
19466
38932
58398
77864
97330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.706 AC: 106352AN: 150692Hom.: 37746 Cov.: 28 AF XY: 0.713 AC XY: 52456AN XY: 73610 show subpopulations
GnomAD4 genome
AF:
AC:
106352
AN:
150692
Hom.:
Cov.:
28
AF XY:
AC XY:
52456
AN XY:
73610
Gnomad4 AFR
AF:
AC:
0.615532
AN:
0.615532
Gnomad4 AMR
AF:
AC:
0.797555
AN:
0.797555
Gnomad4 ASJ
AF:
AC:
0.687283
AN:
0.687283
Gnomad4 EAS
AF:
AC:
0.910841
AN:
0.910841
Gnomad4 SAS
AF:
AC:
0.737098
AN:
0.737098
Gnomad4 FIN
AF:
AC:
0.778
AN:
0.778
Gnomad4 NFE
AF:
AC:
0.711269
AN:
0.711269
Gnomad4 OTH
AF:
AC:
0.714354
AN:
0.714354
Heterozygous variant carriers
0
1585
3170
4755
6340
7925
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
824
1648
2472
3296
4120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=14/86
disease causing (long InDel)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at